Advertisement
INGN vs STRRP
Which Stock Would AI Choose? Inogen (INGN) vs. Star Equity Holdings (STRRP) Stock Comparison
Key Takeaways
- INGN is a common stock of a medical-device maker in an active turnaround, while STRRP is a preferred (income-oriented) security that pays a fixed 10% coupon.
- Inogen is shifting from portable oxygen concentrators into a broader respiratory-care platform, with international growth offsetting U.S. channel pressure.
- STRRP carries meaningful income (~10–11% yield) but reflects the credit and cash-flow risk of a small-cap holding company, including a history of dividend shortfalls.
- The two instruments appeal to different investors: capital-appreciation seekers versus income-focused holders, making a direct "apples-to-apples" comparison limited.
- INGN is unprofitable but debt-free with a growing total addressable market; STRRP's value hinges on Star Equity's ability to consistently fund its preferred dividend.
Introduction
Comparing INGN and STRRP is less a contest between two similar companies than a study in contrasting security types and risk profiles. Inogen, Inc. is a common-stock holding in a respiratory medical-device business working through a strategic transformation. STRRP is the Nasdaq-listed Series A cumulative perpetual preferred stock of Star Equity Holdings, a diversified holding company. Because one represents equity upside and the other a fixed-income-style yield, this stock comparison is most useful for traders and investors weighing growth potential against current income, and for anyone evaluating how market positioning, momentum, and catalysts differ across the two.
INGN Overview and Recent Performance
INGN (Inogen, Inc.) designs and sells respiratory products, most notably portable oxygen concentrators (POCs) for patients with chronic respiratory conditions. In recent quarters the company has broadened beyond its POC roots into sleep therapy, airway clearance, and digital health, expanding its estimated total addressable market to more than $3.4 billion. Recent results reflect this pivot: first-quarter 2026 revenue grew 3.4% year over year to roughly $85.1 million, led by 18% international growth, while U.S. sales and rentals softened as the domestic market continues migrating toward POCs.
Sentiment has been shaped by several developments. Management divested its U.S. oxygen rental business for up to $25 million and increased its share repurchase authorization to $45 million, moves aimed at simplifying the model and returning capital. The company remains unprofitable on a GAAP (Generally Accepted Accounting Principles) basis but carries no debt and held roughly $93 million in cash at the close of the most recent quarter. Analyst consensus sits at a "Buy," with price targets implying substantial upside from the current low-single-digit share price. Recent market activity has been volatile, with the stock trading both above and below its 20-day moving average in recent weeks.
STRRP Overview and Recent Performance
STRRP is the 10% Series A cumulative perpetual preferred stock of Star Equity Holdings, a diversified multi-industry holding company. The security pays a fixed $1.00 per year ($0.25 per quarter), and at recent prices near $9.20–$9.90 it offers a current yield of roughly 10–11%. The underlying company operates through Building Solutions, Business Services (recruitment under the Hudson Talent Solutions brand), Energy Services, and Investments, following its 2025 merger with Hudson Global.
Recent performance has been relatively range-bound, with the preferred trading in a 52-week band near its $10 stated value. Key developments include regular quarterly dividend declarations and the company's announced acquisition of Harte Hanks at $5.00 per share, a deal structured in part using STRRP preferred shares. However, the instrument carries credit-like risks: the issuer has a history of partial or missed dividends, and recent quarters have shown negative operating cash flow. Trading volume is thin, which can amplify price moves relative to more liquid equities.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection from Tickeron's library of hundreds of AI trading bots, which together monitor and trade thousands of different tickers. Rather than featuring every available robot, this section surfaces only those whose strategies, risk profiles, and recent statistics are best aligned with current market conditions. The bots span varied trading styles and timeframes, with differing win rates, trade frequencies, and ticker coverage, so investors can filter by the metrics that matter most to them. Whether the goal is short-term momentum or longer-horizon positioning, exploring the Trending AI Robots page can help identify automated approaches currently resonating with the market.
Head-to-Head Comparison
The clearest contrast between INGN and STRRP is the nature of the instrument itself. INGN offers pure equity exposure to a single medical-device franchise with genuine growth optionality but no current dividend and persistent net losses. STRRP offers a fixed, high-yield income stream but limited upside, since preferred stock generally trades near par and lacks meaningful capital-appreciation potential.
Growth drivers also diverge sharply. INGN's narrative rests on new product launches, international expansion, and an expanding addressable market. STRRP's return depends on Star Equity's ability to generate consistent cash flow across cyclical segments — including a building-solutions unit currently facing soft demand and a shrinking backlog — sufficient to fund the preferred dividend. Risk factors differ as well: INGN faces execution and reimbursement risk in healthcare markets, while STRRP carries credit risk, thin liquidity, and historical dividend-shortfall risk. On market sentiment, INGN shows higher volatility with analyst support, whereas STRRP behaves more like a stable, income-oriented instrument with limited coverage.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely treat these two securities differently rather than rank them on a single scale. For trend consistency and relative momentum, INGN may present a more dynamic profile, with clearer catalysts, analyst conviction, and a debt-free balance sheet supporting its transformation, albeit with greater volatility and continued losses. For stability and current income, STRRP offers a predictable coupon but limited upside and meaningful credit sensitivity. In probabilistic terms, an AI framework oriented toward capital appreciation and trend momentum would tend to favor INGN, while a yield- and stability-weighted framework would lean toward STRRP. The appropriate choice depends on the investor's objective rather than any single universal ranking.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INGN is a Hold and STRRP is a Hold.
INGN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 06, 2026
INGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 40 cases where INGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for INGN crossed bullishly above the 50-day moving average on October 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +5.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where INGN advanced for three days, in 190 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 115 of 169 cases where INGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day RSI Indicator for INGN moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 25 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 54 of 58 cases where INGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INGN as a result. In 70 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for INGN turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 39 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.915) is normal, around the industry mean (4.142). P/E Ratio (-6.626) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.393) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. INGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
STRRP's RSI Indicator recovers from oversold territory
The RSI Oscillator for STRRP moved out of oversold territory on October 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In 7 of the 12 cases the stock moved higher. This puts the odds of a move higher at 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 71 cases where STRRP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 55%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on STRRP as a result. In 60 of 138 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 43%.
The Moving Average Convergence Divergence (MACD) for STRRP just turned positive on October 29, 2026. Looking at past instances where STRRP's MACD turned positive, the stock continued to rise in 28 of 68 cases over the following month. The odds of a continued upward trend are 41%.
Following a +2.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where STRRP advanced for three days, in 75 of 183 cases, the price rose further within the following month. The odds of a continued upward trend are 41%.
STRRP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for STRRP moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRRP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 35%.
The Aroon Indicator for STRRP entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (4.795). P/E Ratio (0.000) is within average values for comparable stocks, (1.381). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.448). Dividend Yield (0.112) settles around the average of (1.499) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (0.884).
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. STRRP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRRP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
INGN | STRRP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 58 | 58 | |
P/E GROWTH RATING 1..100 | 37 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STRRP's Valuation (10) in the null industry is somewhat better than the same rating for INGN (53) in the Medical Specialties industry. This means that STRRP’s stock grew somewhat faster than INGN’s over the last 12 months.
STRRP's Profit vs Risk Rating (100) in the null industry is in the same range as INGN (100) in the Medical Specialties industry. This means that STRRP’s stock grew similarly to INGN’s over the last 12 months.
INGN's SMR Rating (94) in the Medical Specialties industry is in the same range as STRRP (100) in the null industry. This means that INGN’s stock grew similarly to STRRP’s over the last 12 months.
INGN's Price Growth Rating (58) in the Medical Specialties industry is in the same range as STRRP (58) in the null industry. This means that INGN’s stock grew similarly to STRRP’s over the last 12 months.
INGN's P/E Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for STRRP (100) in the null industry. This means that INGN’s stock grew somewhat faster than STRRP’s over the last 12 months.
| INGN | STRRP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 55% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 43% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 41% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 37% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 39% |
| Advances ODDS (%) | 8 days ago 71% | 2 days ago 41% |
| Declines ODDS (%) | 6 days ago 81% | 17 days ago 35% |
| BollingerBands ODDS (%) | 2 days ago 75% | 2 days ago 53% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 49% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INGN’s FA Score shows that 0 FA rating(s) are green while STRRP’s FA Score has 1 green FA rating(s).
- INGN’s FA Score: 0 green, 5 red.
- STRRP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INGN’s TA Score shows that 4 TA indicator(s) are bullish while STRRP’s TA Score has 6 bullish TA indicator(s).
- INGN’s TA Score: 4 bullish, 5 bearish.
- STRRP’s TA Score: 6 bullish, 3 bearish.
Price Growth
INGN (@Medical/Nursing Services) experienced а -14.53% price change this week, while STRRP (@Other Consumer Services) price change was +2.25% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Other Consumer Services industry was +184.51%. For the same industry, the average monthly price growth was +167.45%, and the average quarterly price growth was +174.88%.
Reported Earning Dates
INGN is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Other Consumer Services (+184.51% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
Advertisement
INGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, INGN has been loosely correlated with IRTC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then IRTC could also see price increases.
| Ticker / NAME | Correlation To INGN | 1D Price Change % | ||
|---|---|---|---|---|
| INGN | 100% | -1.88% | ||
| IRTC - INGN | 47% Loosely correlated | -3.01% | ||
| VCYT - INGN | 46% Loosely correlated | -7.18% | ||
| STRRP - INGN | 44% Loosely correlated | +0.89% | ||
| OSUR - INGN | 39% Loosely correlated | -5.67% | ||
| OFIX - INGN | 38% Loosely correlated | -9.87% | ||
More | ||||
STRRP and
Correlation & Price change
A.I.dvisor indicates that over the last year, STRRP has been closely correlated with CVRX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRRP jumps, then CVRX could also see price increases.
| Ticker / NAME | Correlation To STRRP | 1D Price Change % | ||
|---|---|---|---|---|
| STRRP | 100% | +0.89% | ||
| CVRX - STRRP | 67% Closely correlated | -10.93% | ||
| ACRS - STRRP | 52% Loosely correlated | -2.12% | ||
| ANGO - STRRP | 48% Loosely correlated | -0.41% | ||
| ELUT - STRRP | 46% Loosely correlated | +11.60% | ||
| INGN - STRRP | 44% Loosely correlated | -1.88% | ||
More | ||||